Table 3

Predictive factors of early (30-day or in-hospital) mortality after TAVI

Adjusted OR (95% CI)p ValuePoints for score (/21)
Age (years)
 <9010
 ≥901.53 (1.02 to 2.30)0.041
Body mass index (kg/m²)
 ≥3010
 18.5–29.91.51 (1.01 to 2.27)0.0471
 <18.52.27 (1.09 to 4.74)0.033
NYHA class IV1.79 (.26 to 2.54)0.0012
Pulmonary oedema (APE)
 <2 APE last year10
 ≥2 APE last year1.61 (1.12 to 2.30)0.012
Pulmonary hypertension (systolic PAP ≥60 mm  Hg)1.45 (1.08 to 1.94)0.011
Critical state*2.39 (1.42 to 4.02)0.0013
Respiratory insufficiency†1.64 (1.22 to 2.20)0.0012
Dialysis2.88 (1.46 to 5.66)0.0024
Approach
 Transfemoral or subclavian10
 Transapical2.02 (1.47 to 2.78)<0.00012
 Other2.18 (1.11 to 4.28)0.023
  • Multivariate analysis in the development cohort and definition of the score.

  • APE, acute pulmonary oedema; NYHA, New York Heart Association; PAP, pulmonary artery pressure; TAVI, transcatheter aortic valve implantation.

  • *Any one or more of the following: ventricular tachycardia or fibrillation or aborted sudden death, preoperative cardiac massage, preoperative ventilation before arrival in the anaesthetic room, preoperative inotropic support, intra-aortic balloon counterpulsation or preoperative acute renal failure (anuria or oliguria <10 mL/h).

  • †Obstructive or non-obstructive symptomatic respiratory disease.